Connect with us

Cannabis News

Cannabis Seed Oil Has ‘Superior Effectiveness’ In Healing Wounds Compared To Conventional Antibiotics, Study Shows

Published

8 months ago

on

Cannabis seed oils can help accelerate the healing of skin wounds. The authors say that “HEMP seed oil can help with wound management and cost effective”.

Report, published in the journal Narra J, compared hypsea oils against oil against treats treated with conventional antibiotics chlorampenicol. Another group of mice only gave salt solution.

“The findings of the study of the healing processes of the wounds, especially the processes of healing wounds, epithelialization, granulation tissue formation and vascularization.

The four-person research team of Indonesia Universitas Syiah, has not been taken into account that the treatment of Hamp oil has exceeded the treatment of the healing process that surpassed treatment with chlorampenicol. The other season, however, seemed to be “comparable to antibiotic.

“Kalametro seed oil showed the effectiveness of the rapid sized size,” the paper said. In terms of epithelialization, the significant effects of the two treatments, the seed oils in today’s research can provide special benefits in this critical phase of wound healing, potentially accelerating a hundred retraining transition. “

In terms of fabric formation, the treatment of the HEMP Seed was significantly accelerated in the formation of the formation of granulation, especially in 14 days, where he wrote “.” However, the effect of 21 days was comparable with chlorampenicol “.

“Hemp seed oil showed great potential to speed healing processes, especially the reduction of wound size, epithelialization, granulation tissue formation and vascularization.

“According to the day, the treatment of hemp seed oil is more pronounced with chlorampenicol and control groups compared to chlorampenicol and control groups, even if the fibers were somewhat disorganized,” reports follow. “Depending on the day, according to the year, the granulation fabric in the treatment of hemp seed oil indicates the most advanced and well-organized structure, compared to chloramphenicol and control groups.”

The results showed HEMP Seed oil treatment “21 days of vascularization has increased significantly, no effect 3, 7, or 14 days”

“Day 21, vascularization, chalmu-seed oil treatment, chlorophenicol and negative control groups, basascularization, forming new blood vessels …” The critical role of the healing of the wounds is the new formation of the blood vessel. “

As for the mechanisms working in the treatment of cannabis, the authors were “combined activities” of multiple compounds.

“HEMP seed oil has different bioactive ingredients, each has the potential to accelerate the specific phases of the wound healing”, they write:

“Polyminstrated fatty acids, regulating the inflammatory phase, which reduce the inflammatory phase. Terpenoids and flavonoids, which reduce oxidizing stress, cannabinoids. Cannapidiols shows inflammatory and antimicrobial effects, essential for infection control and balanced immune responses. “

“The combined actions of these compounds proposed that HEMP seed oil can improve wounds in many ways,” exam says “effectively addressing the inflammatory and abundance stages.”

Reports on the consequences of various compounds “The basic combined oil has wound healing, such as Sesame, Kalamu, wild pistachio and walnut oils.

But “While combined formulations take advantage of the bioactive compounds of multiple oils, the specific contributions of individual components were not clear,” continues. “Hemp seed oils, as a single agent treatment, facilitates formulations and prevents potential interactions between bioactive compounds, but it still shows a strong therapeutic potential.”

New study It is added to an emerging body of scientific evidence to treat the potential of cannabinoids in order to treat wounds and deal with many other skin conditions.

Review published last year at Journal Pharmaceutics, for example, is found Cannabis oil offered “hopeful advantages” to help heal skin wounds Although the need to improve product formulas.

Researchers from Indian and Thai Universities, Cannabis Oils can see how “Ros-Reactive Oxygen Species (ROS) can reduce wounds when healing. These chemicals “is essential in development in development causing cells and tissue damage,” he explains

The authors of this study wrote cannabis oils “can help alleviate oxidant damage by promoting the mechanisms of Ros and antioxidants, to potentially improve wounds.”

“Cannabis oils, especially in its bioactive components, especially through the regulation of the skin wounds, through the regulation of the reactive oxygen species,” they wrote that the antioxidant properties of CBD increases Rose’s influences. “

Separate research published this year were found to be CBD as well Useful edition of some skin products as well as evidence of aging and antioxidant properties and wound healing.

“Generally, CBD has many features that can be used to develop cosmecimal products in cosmecimal products, such as sun protection products, and wounds to develop healing products.

In terms of wound healing, the discovery of the study “CBD has an impact on the expression of key genes involved in all phases of the wound healing process, protecting the potential for skin repair and anti-aging applications as a therapeutic agent.”

In the dermatology of clinical, cosmetical and researchers carried out in the journal, he found that Cannabidiol (CBD) and cannabigerol (CBG) Ointment “was effective in patients with eczema” to reduce efficiency and improve quality of life ““In some cases the symptom causes forgiveness.”

Transdermal ointment was used as an alternative to “regular therapy for” July 2022, “the results we wrote.” The results of the skin (water loss) were improved in sites studied (obstiments). “

Seeing a different research in the Dental Products CBDA, a CBD mouthwash and another botanical extraction can be a useful tool for promoting oral health Controlling the plate by controlling and reducing oral bleeding.

“The available evidence suggests that CBD is emphasizing the potential of anti-inflammatory, neurophodies, neurophodies, neurophatives, neuroprosters and antimicrobials,” the authors wrote.

Another paper published last year, published in the journal American Academy of Dermatology, found that Applying CBD-infused cream, ultraviolet (UV) is a lower risk of damage to ray exposure. Among those who used CBD cream, 21 percent had less damage than the control group, which received placebo. 47 percent of the other percent had compactive damage, and 11 percent show better results in front of the civet of the placebo’s cannabis.

Potential benefits are not limited to human applications.

A separate study published in the journal Limitary Science Limitations, which concluded that cannabis Treatment of dogs with plain surface diseases appear to be a “viable alternative”-Spezially if they have harmful side effects of some traditional steroid therapies

This study determined the effectiveness of the whole spectrum CBD oil in the autoimmune disease of a dog Lupus Eritematos (DLE). The condition that causes hair loss and redness can usually be treated with other corticosteroids and other drugs that can place a tension in the liver of a dog.

A veterinarian gave full spectrum oil with 2: 1 thc: CBD ratio, at once, a drop of day a day until three days and gradually increases until the optimal dose of symptoms. “

“In a few weeks, the dog has shown significant improvement in dermatological signals, accompanied by an improvement in the same period of the liver function,” the examination said. “It is interesting that the owner learned about an improvement of the dog’s behavior of the prednisolonus and receiving cannabis oil and within the first day.”

Photo courtesy Kimzy Nanney.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

From photobiology to dynamic lighting strategies in greenhouse production

Published

10 hours ago

on

April 9, 2026

By

Greenhouse growers are working in conditions where crop yield and energy use must be managed simultaneously. According to Timo Spruijt, Chief Customer Officer at RED Horticulture, this requires a shift from fixed lighting schedules to approaches based on plant light responses.

“Lighting is moving from static control to measured and predictable strategies,” says Timo. “That starts with understanding how plants react to light and translating that into everyday decisions.”

© RED Horticulture

This approach is based on photobiology, which links plant development to light conditions. Two parameters are central: intensity and spectrum. Light intensity affects photosynthesis, biomass accumulation and yield, while spectrum affects morphology, flowering, rooting and nutritional composition. Paul Vailhen, photobiologist at RED, points out that these factors must be managed together. “Focusing on one parameter without the other limits how plants use light. The interaction between intensity and spectrum determines photon efficiency.”

He explained that growers can use this knowledge to target harvests more precisely. “When photobiology is applied in practice, lighting becomes a management tool rather than a fixed input.”

Three areas
To support this, RED Horticulture organizes its offer around three areas: luminaires, control platform and agronomic orientation. These components are intended to respond to changes during the day and during the cultivation phases. “The needs of the plants are not constant,” says Timo. “Lighting strategies must follow these variations.”

The MyRED platform is used to translate greenhouse data into lighting decisions. Growers can monitor performance and adjust lighting strategies through a dashboard. “The platform allows producers to define and modify their light recipes and evaluate the results,” explains Timo. “It links crop data with energy use.”

He added that implementation goes beyond software. “Support continues after installation. We work with growers to set goals, apply strategies and adjust over time.”

Energy use
Energy use is a major factor in greenhouse operations. Timo connects lighting strategies directly with consumption. “Understanding how intensity and spectrum affect power use helps growers manage their energy input,” he says. “This could lead to changes in the way lighting is applied during the day.”

Automation is also part of today’s greenhouse practices. The system can adjust the lighting throughout the day according to predefined strategies. “Automation reduces manual adjustments and keeps light levels consistent,” says Timo. “It also allows control over the entire light output.”

He noted that automated control can contribute to additional energy savings beyond the performance of the luminaires. “When strategies are applied dynamically, further reductions in energy use are possible.”

Research
This is another part of the research approach. Through the Photobiology and Agronomy Research Center (PARC), RED Horticulture conducts trials under controlled conditions. Timo explains how this relates to commercial production. “Trials allow strategies to be tested before implementation. Producers can then apply these results with a clearer view of expected outcomes.”

The goal is to make photobiology applicable to different crops and growing environments. “The same principles can be adapted to different varieties and production systems,” says Timo. It concludes by returning to the role of knowledge in greenhouse management. “Understanding photobiology is the starting point. From there, growers can build lighting strategies that match crop requirements and energy constraints.”

For more information:
RED Horticulture
World Horti Center
Europe 1
2672 ZX Naaldwijk
+31 174 705 617
horticulture.red/

Continue Reading

Cannabis News

Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force Charged With Studying Psilocybin And MDMA

Published

10 hours ago

on

April 9, 2026

By

Another Hawaii House committee has passed the Senate-passed bill creating a psychedelic task force responsible for analyzing and making policy recommendations about providing access to breakthrough therapies like psilocybin and MDMA.

The House Finance Committee advanced the legislation to Sen. Chris Lee (D) on a 15-0 vote Tuesday. The measure, which passed the Senate last month by a 24-0 vote, will next go to the House floor before returning to the Senate for that chamber to consider final amendments.

The bill would create Creative Mental Health Therapy, a two-year review of the current scientific literature, supporting additional clinical research and developing policy recommendations for the “safe, ethical, and culturally informed implementation” of a psychedelic therapy program.

“The Legislature believes in addressing the mental health crisis affecting the State’s residents, particularly among veterans, first responders and trauma survivors,” SB 3199 reads. “Suicide remains the leading cause of preventable death, and the State must explore all safe and effective treatment options supported by scientific evidence.”

Given that the Federal Food and Drug Administration (FDA) has designated psilocybin and MDMA as breakthrough therapies in the treatment of serious mental health conditions, which may be subject to future control under the Controlled Substances Act (CSA), Hawaii’s legislation states that the state must “proactively prepare public health, clinical and research systems for safe and equitable implementation.”

The state Department of Health said in House committee testimony that it supports the bill, noting that in light of the FDA’s action on psychedelics, it is “prudent for Hawaii to assess research readiness, regulatory implications, workforce development and culturally informed implementation pathways” before any federal rescheduling of the substances.

The Governor’s Office of Wellness and Resiliency said the bill “has an important opportunity to begin paving a planned pathway for people who need access to life-saving treatments for trauma and other mental health issues.”

“A growing body of research demonstrates that breakthrough therapies (such as MDMA and psilocybin-assisted therapies) demonstrate high efficacy and positive clinical outcomes in the treatment of post-traumatic stress disorder, substance use disorders, end-of-life anxiety, eating disorders, depression, treatment-resistant, and additional conditions in terminally ill patients.”




Team members should include representatives from the State Department of Health (DOH), the Office of the Attorney General, the Office of Wellness and Resiliency (OWR), the University of Hawaii School of Medicine, and more.

Like the draft, the DOH would oversee the task force, an amendment approved by the House Health Committee last month makes the University of Hawaii John A. Burns School of Medicine (JABSOM) the responsible institution, and JABSOM’s nominee as the panel’s chairman.

The commission also adopted amendments suggested by the Department of Law Enforcement to say that its Division of Narcotics Enforcement — and not the Board of Pharmacy — would be responsible for changing the state’s scheduling of psychedelics after any federal reclassification, and to change the deadline for doing so from 90 days to 30 days.

Members note in their bill report that the state Agency for Health Planning and Development has expressed concern that psychedelics are illegal under federal law and that the task force should proceed with caution.

Finally, the panel made technical corrections for clarity, consistency, and style.

If ordered, it appears invoice would be It was first assembled in 2023 based on prior work by a separate psychedelic task force.With a similar goal of exploring avenues for therapeutic access in breakthrough drugs approved by the FDA such as psilocybin.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Meanwhile, Hawaii senators recently passed a bill to legalize low-dose, low-potency marijuanathe legislation did not advance the necessary steps before a crucial deadline, so it is dead for the year.

A separate marijuana legalization bill, SB 2421, that contained provisions under federal reform law or amendments to the state Constitution, was delayed for action. The Senate and House panels also delayed action on a measure to sell certain hemp-derived cannabinoid products.

These actions follow Senior lawmakers in the House indicated that proposals to legalize cannabis would not move forward In the 2026 session, citing the lack of sufficient support in their chamber.

Earlier this month, a Hawaii Senate committee unanimously approved legislation to allow patients immediately enter medical cannabis after submitting their recordsinstead of waiting for the cards to be delivered, as is the case under current legislation.

A Senate committee also adopted the resolutions Asking Congress to federally legalize marijuanasupport the state’s efforts to clean up people’s criminal records and take steps to make it easier for cannabis companies to access banking services.

Another Senate panel advanced separate resolutions urging the state attorney general and the health department to seek a waiver from the Drug Enforcement Administration (DEA). Hawaii is allowed to run its cannabis program without federal interference.

user photo Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Rescheduling appeal process ‘remains pending’ despite Trump’s executive order

Published

1 day ago

on

April 8, 2026

By











The Drug Enforcement Administration (DEA) says the marijuana redistricting appeals process “remains pending” despite President Donald Trump issuing an executive order more than three months ago ordering the attorney general to pursue reform “as expeditiously as possible.”

The DEA and reform advocates filed a joint status report Monday on the agency’s interlocutory appeal of bias and improper communications with parties opposed to the redistricting.

“To date, the Movants’ interlocutory appeal to the Administrator on the Motion for Reconsideration remains pending with the Administrator,” said attorneys representing the DEA and cannabis reform advocates who are challenging the process. “No information schedule has been established.”

The agency is responsible for establishing the information schedule. But nearly a year after a former administrative law judge granted the appeal, the DEA is once again delaying the process. This is the fifth consolidated status report, with largely identical language, that the parties have submitted under the administrative litigation order.

Read more Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media